Interacting Drugs |
Pneumococcal polysaccharide vaccine (23-valent) vs Zoster Vaccine |
Security Level |
 |
Mechanism |
Zoster Vaccine: Pneumococcal Polysaccharide Vaccine (Polyvalent) may diminish the therapeutic effect of Zoster Vaccine. |
Management |
Consider therapy modification |
Pneumococcal polysaccharide vaccine (23-valent) vs Zoster Vaccine
Post Review about Pneumococcal polysaccharide vaccine (23-valent) vs Zoster Vaccine Click here to cancel reply.
Other Interactions of Pneumococcal polysaccharide vaccine (23-valent)
Other Interactions of Zoster Vaccine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.